SiliconInvestor
     Advanced Search   [ sign in ]

register
Sponsor		  register
Register

 Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: Cacaito who wrote (23048)1/5/2001 5:09:51 PM
From: FrostmanRead Replies (1) of 23464
 
Cacaito, If you are mostly correct regarding the FDA's position, Vivus has some hard decisions to make on Alibra. I wonder if one of their considered choices is to scrap the project, and put the focus on their third generation ED therapy. Interesting. The best decision builds or conserves the most cash.

They will say nothing until they are 100% certain.

Dapoxetine. How long do you think it will take to get it to market?

Thank you for the information!

Frostman
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.